Related references
Note: Only part of the references are listed.Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model
Ming-Hong Hsieh et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
Adalberto A. Castro et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease
D. W. Luchtman et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Early onset deficits on the delayed alternation task in the HdhQ92 knock-in mouse model of Huntington's disease
R. C. Trueman et al.
BRAIN RESEARCH BULLETIN (2012)
Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb
Lisa Glasl et al.
EXPERIMENTAL NEUROLOGY (2012)
Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice
Shigeki Moriguchi et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Depression in Parkinson disease-epidemiology, mechanisms and management
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2012)
Measuring impulsivity in mice: the five-choice serial reaction time task
Sandra Sanchez-Roige et al.
PSYCHOPHARMACOLOGY (2012)
Exercise and Parkinson's: benefits for cognition and quality of life
K. E. Cruise et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: A cautionary note
Alexander Klein et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: Potential for treatment of Parkinson's disease dementia
Ying-Jui Ho et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats
Julia Jungnickel et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Parkinson's disease risk from ambient exposure to pesticides
Anthony Wang et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Treatment of depressive symptoms in Parkinson's disease
P. Barone
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency
S. Vuillermot et al.
GENES BRAIN AND BEHAVIOR (2011)
Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake
Hongxia Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Changes in Executive Function After Acute Bouts of Passive Cycling in Parkinson's Disease
Angela L. Ridgel et al.
JOURNAL OF AGING AND PHYSICAL ACTIVITY (2011)
Dynamics of Executive Control and Motor Deficits in Parkinsonian Rats
Alain Courtiere et al.
JOURNAL OF NEUROSCIENCE (2011)
Elevated Tonic Extracellular Dopamine Concentration and Altered Dopamine Modulation of Synaptic Activity Precede Dopamine Loss in the Striatum of Mice Overexpressing Human α-Synuclein
Hoa A. Lam et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Synuclein deposition and non-motor symptoms in Parkinson disease
Kurt A. Jellinger
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Parkinson disease The enteric nervous system spills its guts
P. Derkinderen et al.
NEUROLOGY (2011)
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Michael T. Treadway et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease
Jules M. Nazzaro et al.
PARKINSONISM & RELATED DISORDERS (2011)
Multi-organ autonomic dysfunction in Parkinson disease
Samay Jain
PARKINSONISM & RELATED DISORDERS (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Attention-modulating effects of cognitive enhancers
Edward D. Levin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Antidepressant-like properties of sarizotan in experimental Parkinsonism
Xiaoqun Zhang et al.
PSYCHOPHARMACOLOGY (2011)
Endurance training enhances BDNF release from the human brain
Thomas Seifert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse
Lori M. Gorton et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat
Karen L. Eskow Jaunarajs et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
Nicolaas I. Bohnen et al.
BRAIN (2010)
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
Alfonso Fasano et al.
BRAIN (2010)
DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments
T. T. Pham et al.
GENES BRAIN AND BEHAVIOR (2010)
Sleep Disturbances in Parkinson Disease and Their Potential Role in Heterogeneity
David G. Gunn et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2010)
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
Angie A. Kehagia et al.
LANCET NEUROLOGY (2010)
Brain Stem Pathology in Parkinson's Disease: An Evaluation of the Braak Staging Model
Ann E. Kingsbury et al.
MOVEMENT DISORDERS (2010)
Animal models of neuropsychiatric disorders
Eric J. Nestler et al.
NATURE NEUROSCIENCE (2010)
PITX3 polymorphism is associated with early onset Parkinson's disease
Olle Bergman et al.
NEUROBIOLOGY OF AGING (2010)
Selective noradrenergic vulnerability in alpha-synuclein transgenic mice
Evangelos Sotiriou et al.
NEUROBIOLOGY OF AGING (2010)
Intranigral LPS Administration Produces Dopamine, Glutathione but not Behavioral Impairment in Comparison to MPTP and 6-OHDA Neurotoxin Models of Parkinson's Disease
Deborah Ariza et al.
NEUROCHEMICAL RESEARCH (2010)
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
D. Weintraub et al.
NEUROLOGY (2010)
Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters
Chong-Bin Zhu et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice
Julie Deguil et al.
NEUROTOXICITY RESEARCH (2010)
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson's Disease
Rui D. S. Prediger et al.
NEUROTOXICITY RESEARCH (2010)
Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease
Scott Bickel et al.
PARKINSONISM & RELATED DISORDERS (2010)
MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus
Hiu-Ngar Sy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine
Ronise M. Santiago et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
The morbid anatomy of dementia in Parkinson's disease
Michail E. Kalaitzakis et al.
ACTA NEUROPATHOLOGICA (2009)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Risk is in the Air An Intranasal MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Rat Model of Parkinson's Disease
Rui D. S. Prediger et al.
INTERNATIONAL SYMPOSIUM ON OLFACTION AND TASTE (2009)
MPTP Lesion Causes Neuroinflammation and Deficits in Object Recognition in Wistar Rats
Wen-Fu Wang et al.
BEHAVIORAL NEUROSCIENCE (2009)
Rule learning, visuospatial function and motor performance in the HdhQ92 knock-in mouse model of Huntington's disease
R. C. Trueman et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration
Konstantinos Pothakos et al.
BMC NEUROSCIENCE (2009)
Benefits of physical exercise on executive functions in older people with Parkinson's disease
Katia Tanaka et al.
BRAIN AND COGNITION (2009)
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease
Nicoletta Schintu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Olfactory dysfunction as a diagnostic marker for Parkinson's disease
Antje Haehner et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease
Christopher I. Higginson et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2009)
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances
V. Perez et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
Tonya N. Taylor et al.
JOURNAL OF NEUROSCIENCE (2009)
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Thomas S. Guillot et al.
MOLECULAR NEUROBIOLOGY (2009)
Atomoxetine for the Treatment of Executive Dysfunction in Parkinson's Disease: A Pilot Open-Label Study
Laura Marsh et al.
MOVEMENT DISORDERS (2009)
The transcription factor PITX3 is associated with sporadic Parkinson's disease
Julia Fuchs et al.
NEUROBIOLOGY OF AGING (2009)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
The role of the basal ganglia in implicit contextual learning: A study of Parkinson's disease
Marieke van Asselen et al.
NEUROPSYCHOLOGIA (2009)
Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: Effects of pramipexole and pergolide on working memory
Alberto Costa et al.
NEUROPSYCHOLOGIA (2009)
Genetic and Vascular Modifiers of Age-Sensitive Cognitive Skills: Effects of COMT, BDNF, ApoE, and Hypertension
Naftali Raz et al.
NEUROPSYCHOLOGY (2009)
Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease
Elvira De Leonibus et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Striatal Neuroinflammation Promotes Parkinsonism in Rats
Dong-Young Choi et al.
PLOS ONE (2009)
The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder
Gunnar Gustafsson et al.
PSYCHIATRY RESEARCH (2009)
A Critical Evaluation of the Braak Staging Scheme for Parkinson's Disease
Robert E. Burke et al.
ANNALS OF NEUROLOGY (2008)
Bilateral subthalamic stimulation impairs cognitivemotor performance in Parkinsons disease patients
Jay L. Alberts et al.
BRAIN (2008)
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease
Nobukatsu Sawamoto et al.
BRAIN (2008)
7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease
Kristi L. Haik et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2008)
Current management of the cognitive dysfunction in Parkinson's disease: How far have we come?
Salvador Vale
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
α-synuclein transgenic mice exhibit reduced anxiety-like behaviour
Sonia George et al.
EXPERIMENTAL NEUROLOGY (2008)
The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
Garima Dutta et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease
Silke Nuber et al.
JOURNAL OF NEUROSCIENCE (2008)
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model
Igor Branchi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
The search for a curative cell therapy in Parkinson's disease
R. Laguna Goya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease:: a randomised, multicentre study
Karsten Witt et al.
LANCET NEUROLOGY (2008)
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease:: A double-blind, randomized, placebo-controlled study
David Devos et al.
MOVEMENT DISORDERS (2008)
Impaired learning and memory in Pitx3 deficient aphakia mice:: A genetic model for striatum-dependent cognitive symptoms in Parkinson's disease
Paul Ardayfio et al.
NEUROBIOLOGY OF DISEASE (2008)
Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury
Marta G. Vuckovic et al.
NEUROBIOLOGY OF DISEASE (2008)
EMOTIONAL, COGNITIVE AND NEUROCHEMICAL ALTERATIONS IN A PREMOTOR STAGE MODEL OF PARKINSON'S DISEASE
M. T. Tadaiesky et al.
NEUROSCIENCE (2008)
Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits
Yuxin Liu et al.
NEUROTOXICOLOGY (2008)
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
Gloria E. Meredith et al.
PARKINSONISM & RELATED DISORDERS (2008)
A systematic review of prevalence studies of depression in Parkinson's disease
Jennifer S. A. M. Reijnders et al.
MOVEMENT DISORDERS (2008)
Spatial deficits in a mouse model of Parkinson disease
Elvira De Leonibus et al.
PSYCHOPHARMACOLOGY (2007)
Non-motor behavioural impairments in parkin-deficient mice
Xin-Ran Zhu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
C. H. Williams-Gray et al.
BRAIN (2007)
Th effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats
Martin O'Neill et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2007)
What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression
A. V. Kalueff et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Movement without dopamine: striatal dopamine is required to maintain but not to perform learned actions
E. Dowd et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Cognitive dysfunction and dementia in Parkinson disease
Nuria Caballol et al.
MOVEMENT DISORDERS (2007)
L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease
Roshan Cools et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Evaluation of reward processes in an animal model of depression
David A. Slattery et al.
PSYCHOPHARMACOLOGY (2007)
Olfaction in Parkinson's disease
Richard L. Doty
PARKINSONISM & RELATED DISORDERS (2007)
Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice
Christian Freichel et al.
NEUROBIOLOGY OF AGING (2007)
The dopamine agonist Piribedil with L-DOPA improves attentional dysfunction: Relevance for Parkinson's disease
Nathalie Turle-Lorenzo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cognitive decline correlates with neuropathological stage in Parkinson's disease
Heiko Braak et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease
K. Bronnick et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Effects of the cholesterol-lowering compound methyl-β-cyclodextrin in models of α-synucleinopathy
Pazit Bar-On et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease
R Cools
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
An effect of dopamine depletion on decision-making:: The temporal coupling of deliberation and execution
M Pessiglione et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2005)
Cognitive profile of patients with newly diagnosed Parkinson disease
D Muslimovic et al.
NEUROLOGY (2005)
Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: Histological, neurochemical, motor and memory alterations
MM Ferro et al.
JOURNAL OF NEUROSCIENCE METHODS (2005)
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
P Remy et al.
BRAIN (2005)
Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats
E Dowd et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice
A Mori et al.
NEUROSCIENCE RESEARCH (2005)
Lesion of the substantia nigra, pars compacta impairs delayed alternation in a Y-maze in rats
R Braga et al.
EXPERIMENTAL NEUROLOGY (2005)
Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years
MA Hely et al.
MOVEMENT DISORDERS (2005)
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
AP Carobrez et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat
SB Dunnett et al.
NEUROSCIENCE (2005)
The prefrontal cortex and working memory: physiology and brain imaging
D Passingham et al.
CURRENT OPINION IN NEUROBIOLOGY (2004)
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
T Foltynie et al.
BRAIN (2004)
Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants
E Dowd et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Psychiatric aspects of Parkinson's disease - An Update
A Schrag
JOURNAL OF NEUROLOGY (2004)
Variable effects of chronic subcutaneous administration of rotenone on striatal histology
CN Zhu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone
SM Fleming et al.
EXPERIMENTAL NEUROLOGY (2004)
Systematic review of antidepressant therapies in Parkinson's disease
TH Chung et al.
PARKINSONISM & RELATED DISORDERS (2003)
Psychopathological symptoms of depression in Parkinson's disease compared to major depression
U Merschdorf et al.
PSYCHOPATHOLOGY (2003)
Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system
A Mura et al.
MOVEMENT DISORDERS (2003)
High frequency stimulation of the subthalamic nucleus has beneficial anti parkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task
Y Darbaky et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Mutations in NR4A2 associated with familial Parkinson disease
WD Le et al.
NATURE GENETICS (2003)
Neuropsychological profile of patients with Parkinson's disease without dementia
C Janvin et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns
ME Ragozzino
NEUROBIOLOGY OF LEARNING AND MEMORY (2003)
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
JL Tillerson et al.
EXPERIMENTAL NEUROLOGY (2002)
Memory and executive function impairment predict dementia in Parkinson's disease
G Levy et al.
MOVEMENT DISORDERS (2002)
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
TW Robbins
PSYCHOPHARMACOLOGY (2002)
Preclinical models: Status of basic research in depression
EJ Nestler et al.
BIOLOGICAL PSYCHIATRY (2002)
Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7
V Bonifati et al.
NEUROLOGICAL SCIENCES (2002)
PARK6 is a common cause of familial parkinsonism
EM Valente et al.
NEUROLOGICAL SCIENCES (2002)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Effect of reboxetine on depression in Parkinson's disease patients
MR Lemke
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Parkinson's disease, pesticides and mitochondrial dysfunction
P Jenner
TRENDS IN NEUROSCIENCES (2001)
Share Paper
